Skip to main content
Clinical Trials/CTRI/2024/02/062277
CTRI/2024/02/062277
Not yet recruiting
Phase 4

Effectiveness of melatonin prophylaxis on the post-operative pain and sensory recovery following mandibular fractures - A Randomized controlled clinical trail

Dr M Sai Shruthi1 site in 1 country24 target enrollmentStarted: February 9, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Dr M Sai Shruthi
Enrollment
24
Locations
1
Primary Endpoint
Sensory recovery

Overview

Brief Summary

Title of the study is Effectiveness of melatonin prophylaxis on post-operative pain and sensory recovery following mandibular fractures- a randomised controlled clinical trial. Aim of the study is to evaluate the effectiveness of melatonin prophylaxis on sensory recovery and post operative pain following surgery after mandibular fractures. The primary objective is to evaluate the efficacy of melatonin prophylaxis on sensory recovery. The secondary objective is to assess the efficacy of melatonin in reducing post surgical pain and numbness. the sample of the study is 24. 12 samples will be taken for each group, so a total of 24 samples will be taken and divided into two groups: study group and control group. The inclusion criteria is patients between 18 to 55 years coming to the hospital with mandibular fractures, and those who are fit for surgery under GA. The exclusion criteria is pregnancy and breastfeeding, renal and hepatic dosing, blood pressure, diabetic mellitus, autoimmune condition, patients consuming anti platelet drugs, anti coagulant drugs, anti convulsants,CNS depressants, seizure threshold lowering drugs, fluvoxamine, contraceptive drugs

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 55.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1 Patient fit for surgical procedure under general anesthesia 2 Patient reporting to the department OPD with mandibular fractures 3 Patient willing to participate in the study.

Exclusion Criteria

  • 1 Pregnancy and breast feeding 2 Hepatic dosing 3 Renal dosing 4 Auto Immune condition 5 Patient consuming anti platelet drugs 6 Patient consuming anti coagulant drugs 7 Patient consuming anti convulsant drugs 8 Patient consuming anti epileptic, CNS depressants drugs 9 Patients consuming oral contraceptives 10 Patient not willing to participate in the study.

Outcomes

Primary Outcomes

Sensory recovery

Time Frame: Post operative day 7,30 and 90

Secondary Outcomes

  • Post surgical pain & numbness(Post surgical pain - Post operative Day 1,3 & 7)

Investigators

Sponsor
Dr M Sai Shruthi
Sponsor Class
Other [Self ]
Responsible Party
Principal Investigator
Principal Investigator

M Sai Shruthi

Sri Venkateshwaraa Dental College

Study Sites (1)

Loading locations...

Similar Trials